Filewrapper

Federal Circuit Clarifies Standard for Determining Nexus Between Claims and Secondary Considerations

By Julie L. Spieker

On December 18, 2019, in Fox Factory, Inc. v. SRAM, LLC, the Federal Circuit (the “Court”) vacated and remanded the Patent Appeal Board’s (the “Board”) obviousness determination. Fox challenged SRAM’s patent for bicycle chain rings in an inter partes review. The Court found that the Board applied the wrong standard for determining whether or not challenged […]

Continue Reading →

SUPREME COURT DENIES USPTO ATTORNEY FEES UNDER 35 USC 145

By Kirk M. Hartung

On December 11, 2019, the US Supreme Court ruled against the US Patent & Trademark Office’s recent practice of demanding its attorney fees for patent applications appealed to the U.S. District Court, regardless of whether the Patent Office won or lost.  See Peter v. Nantkwest, Inc., No. 18-801. 35 U.S.C. 145 provides that a patent applicant dissatisfied […]

Continue Reading →

The Verdict is In – Implications on the Supreme Court Ruling Regarding Attorney’s Fees

By Blog Staff

The United States Supreme Court unanimously ruled on December 11, 2019, that the United States Patent and Trademark Office (USPTO) cannot demand repayment of attorney’s fees in district court proceedings brought under 35 U.S.C. § 145. For a summary of the arguments presented during oral arguments, see the author’s previous post here. The opinion written […]

Continue Reading →

“T” is for Tesla and Trademark

By Sarah M.D. Luth

Elon Musk recently revealed that his company “Tesla” was almost branded “Faraday.” On December 1, Musk tweeted “Tesla was almost called Faraday, as [the] original holder of Tesla Motors trademark refused to sell it to us!” When another Twitter user asked how Tesla eventually got the rights to the name, Musk responded “We sent the nicest […]

Continue Reading →

Update from the AIPLA Biotech Committee Meeting

At the recent American Intellectual Property Law Association (AIPLA) conference the AIPLA Biotechnology Committee met to discuss two biotechnology issues: 35 USC 101 legislation and treatment of genetic resources (GR) and traditional knowledge (TK). Bob Stoll, former Commissioner for Patents at the USPTO and member of AIPLA’s 101 taskforce led the 101 discussion as part […]

Continue Reading →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up